AU2003263582A1 - Process for the manufacture of rofecoxib - Google Patents

Process for the manufacture of rofecoxib

Info

Publication number
AU2003263582A1
AU2003263582A1 AU2003263582A AU2003263582A AU2003263582A1 AU 2003263582 A1 AU2003263582 A1 AU 2003263582A1 AU 2003263582 A AU2003263582 A AU 2003263582A AU 2003263582 A AU2003263582 A AU 2003263582A AU 2003263582 A1 AU2003263582 A1 AU 2003263582A1
Authority
AU
Australia
Prior art keywords
rofecoxib
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003263582A
Inventor
Krishna M. Hari
T. V. S. K Vittal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shasun Chemicals and Drugs Ltd
Original Assignee
Shasun Chemicals and Drugs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shasun Chemicals and Drugs Ltd filed Critical Shasun Chemicals and Drugs Ltd
Publication of AU2003263582A1 publication Critical patent/AU2003263582A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/58—One oxygen atom, e.g. butenolide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
AU2003263582A 2003-08-14 2003-08-14 Process for the manufacture of rofecoxib Abandoned AU2003263582A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2003/000271 WO2005016906A1 (en) 2003-08-14 2003-08-14 Process for the manufacture of rofecoxib

Publications (1)

Publication Number Publication Date
AU2003263582A1 true AU2003263582A1 (en) 2005-03-07

Family

ID=34179260

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003263582A Abandoned AU2003263582A1 (en) 2003-08-14 2003-08-14 Process for the manufacture of rofecoxib

Country Status (2)

Country Link
AU (1) AU2003263582A1 (en)
WO (1) WO2005016906A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020106522A1 (en) * 2018-11-21 2020-05-28 Tremeau Pharmaceuticals, Inc. Purified forms of rofecoxib, methods of manufacture and use
US10945992B1 (en) 2019-11-13 2021-03-16 Tremeau Pharmaceuticals, Inc. Dosage forms of rofecoxib and related methods
US11161833B1 (en) 2021-04-09 2021-11-02 Tremeau Pharmaceuticals, Inc. Deuterated etoricoxib, methods of manufacture, and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585504A (en) * 1994-09-16 1996-12-17 Merck & Co., Inc. Process of making cox-2 inhibitors having a lactone bridge
IT1315243B1 (en) * 1999-10-15 2003-02-03 Zambon Spa OXIDATION PROCESS FOR THE PREPARATION OF USEFUL INTERMEDIATES IN THE SYNTHESIS OF DIARYLPYRIDIN

Also Published As

Publication number Publication date
WO2005016906A1 (en) 2005-02-24

Similar Documents

Publication Publication Date Title
IL173456A0 (en) Process for the preparation of 4-amino-3-quinolinecarbonitriles
IL167426A (en) Process for the manufacture of valsartan
IL175743A0 (en) Process for the preparation of thiazolopyrimidines
AU2002247848A1 (en) Methods for the production of minicircles
AU2003260983A1 (en) Processes for the preparation of s-(-)-amlodipine
HUP0600231A2 (en) Novel process for the preparation of 2h-chromenes
AU2002367890A1 (en) Process for the preparation of 4-methyl-thiazole-5-carbaldehyde intermediate
AU2004225794A8 (en) Process for the electrolysis of aluminiumsulfide
HK1095145A1 (en) Process for the preparation of n-arylmorpholinones n-
AU2003263582A1 (en) Process for the manufacture of rofecoxib
PL371583A1 (en) Process for the preparation of 7alpha-methylsteroids
AU2003269482A1 (en) Process for the manufacture of 2,1,3-benzoxadiazole-4-carboxaldehyde
AU2002311059A1 (en) Process for the manufacture of sertraline
AU2003243432A1 (en) Process of making phosphordiamidite compounds
EG24122A (en) Process for the synthesis of 3-cyano-6-alkoxy-7-nitro-4-quinolines
AU2003267541A1 (en) Method for the production of substituted trifluoroethylenes
IL164788A0 (en) Process for the preparation of 3-isochromanone
AU2003300729A1 (en) Process for the preparation of arylamines
AU2003272080A1 (en) Novel process for the preparation of tert-butyl 6-cyano-5-hydroxy-3-oxohexanoate
AU2003223104A1 (en) A process for the preparation of indolymaleimides
AU2003243143A1 (en) 2-methyl-thieno-benzodiazepine process
AU2003245879A1 (en) Method for the production of substituted trifluoroetylenes
AU2003224421A1 (en) Process for the preparation of loratadine
EP1386911A3 (en) Process for the preparation of acyloxybenzenesulfonates
AU2003259544A1 (en) Process for the preparation of gabapentin

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase